Otsubo K, Morita S, Uchida M, Yamasaki K, Kanbe T, Shimizu T
Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Japan.
Chem Pharm Bull (Tokyo). 1991 Nov;39(11):2906-9. doi: 10.1248/cpb.39.2906.
The enantiomers of 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl] propionic acid [(+/-)-1, rebamipide, OPC-12759], a new antiulcer agent that enhances mucosal resistance, were synthesized from optically active alpha-amino acid derivatives of 2(1H)-quinolinone. The key intermediates, alpha-amino acid derivatives, were prepared by asymmetric synthesis and optical resolution. The (+)-1 was about 1.7 times as potent as the (-)-isomer in antiulcer activity against ethanol-induced gastric ulcers.
2-(4-氯苯甲酰氨基)-3-[2(1H)-喹啉酮-4-基]丙酸[(±)-1,瑞巴派特,OPC-12759]是一种新型抗溃疡药物,可增强黏膜抵抗力,其对映体由2(1H)-喹啉酮的旋光性α-氨基酸衍生物合成。关键中间体α-氨基酸衍生物通过不对称合成和拆分制备。在抗乙醇诱导的胃溃疡活性方面,(+)-1的效力约为(-)-异构体的1.7倍。